Go to content
UR Home

The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors

URN to cite this document:
urn:nbn:de:bvb:355-epub-549119
DOI to cite this document:
10.5283/epub.54911
Joachim, Laura ; Göttert, Sascha ; Sax, Anna ; Steiger, Katja ; Neuhaus, Klaus ; Heinrich, Paul ; Fan, Kaiji ; Orberg, Erik Thiele ; Kleigrewe, Karin ; Ruland, Jürgen ; Bassermann, Florian ; Herr, Wolfgang ; Posch, Christian ; Heidegger, Simon ; Poeck, Hendrik
Date of publication of this fulltext: 24 Oct 2023 14:52



Abstract

Background Inter-individual differences in response to immune checkpoint inhibitors (ICI) remain a major challenge in cancer treatment. The composition of the gut microbiome has been associated with differential ICI outcome, but the underlying molecular mechanisms remain unclear, and therapeutic modulation challenging. Methods We established an in vivo model to treat C57Bl/6j mice with the ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons